Carlos J V Simoes

Biography

BSIM² is a start-up company seeking to become an international reference on the use of structural bioinformatics and chemoinformatics for the development of bioactive products to the global markets of the pharmaceutical and biotechnological industries. At present, the main focus of the company is centered on amyloid diseases. The first product of the company’s portfolio is directed against a rare and fatal neurodegenerative disease, and is currently under development. B.Pharm from Universidade de Coimbra. Ph.d in Pharmaceutical and Drug Design from University of leeds. Ph.d In Biochemistry from Universidade de Coimbra

Research Interest

 research in Biotechnology and chemoinformatics